Mylan Nabs AIA Review Of 2 Patents For Teva's Copaxone
The Patent Trial and Appeal Board granted Mylan Pharmaceuticals Inc.'s request for America Invents Act reviews of two patents licensed to Teva Pharmaceuticals USA Inc. for its multiple sclerosis drug Copaxone,...To view the full article, register now.
Already a subscriber? Click here to view full article